374
Participants
Start Date
October 31, 2011
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
VR506
VR506 inhalation powder delivered via a new dry powder inhaler
Placebo
Placebo delivered via a new dry powder inhaler
Vectura Clinical Trial Site 10040, Rochester
Vectura Clinical Trial Site 10021, Upland
Vectura Clinical Trial Site 23014, Vinnytsia
Vectura Clinical Trial Site 10042, Baltimore
Vectura Clinical Trial Site 10003, Charleston
Vectura Clinical Trial Site 10011, Albany
Vectura Clinical Trial Site 10041, Sarasota
Vectura Clinical Trial Site 10010, Sylvania
Vectura Clinical Trial Site 10008, Plymouth
Vectura Clinical Trial Site 10009, Missoula
Vectura Clinical Trial Site 23005, Kharkiv
Vectura Clinical Trial Site 23004, Kharkiv
Vectura Clinical Trial Site 23010, Kharkiv
Vectura Clinical Trial Site 10020, Warrensburg
Vectura Clinical Trial Site 23007, Odesa
Vectura Clinical Trial Site 10035, Omaha
Vectura Clinical Trial Site 10034, Bellevue
Vectura Clinical Trial Site 10015, Omaha
Vectura Clinical Trial Site 23008, Zaporizhzhya
Vectura Clinical Trial Site 23016, Zaporizhzhya
Vectura Clinical Trial Site 10002, Metairie
Vectura Clinical Trial Site 10017, Oklahoma City
Vectura Clinical Trial Site 10039, Waco
Vectura Clinical Trial Site 10019, Boerne
Vectura Clinical Trial Site 10023, Centennial
Vectura Clinical Trial Site 10025, Denver
Vectura Clinical Trial Site 10001, Colorado Springs
Vectura Clinical Trial Site 23013, Donetsk
Vectura Clinical Trial Site 10004, Draper
Vectura Clinical Trial Site 10031, Los Angeles
Vectura Clinical Trial Site 10027, Rolling Hills Estates
Vectura Clinical Trial Site 10016, Vista
Vectura Clinical Trial Site 10014, Rancho Mirage
Vectura Clinical Trial Site 10044, Mission Viejo
Vectura Clinical Trial Site 10038, Fountain Valley
Vectura Clinical Trial Site 10022, Orange
Vectura Clinical Trial Site 23015, Simferopol
Vectura Clinical Trial Site 10033, San Jose
Vectura Clinical Trial Site 10024, Portland
Vectura Clinical Trial Site 10028, Medford
Vectura Clinical Trial Site 21005, Timișoara
Vectura Clinical Trial Site 21004, Cluj-Napoca
Vectura Clinical Trial Site 21009, Cluj-Napoca
Vectura Clinical Trial Site 21010, Cluj-Napoca
Vectura Clinical Trial Site 21013, Judetul Cluj
Vectura Clinical Trial Site 21002, Brasov
Vectura Clinical Trial Site 21001, Târgu Mureş
Vectura Clinical Trial Site 21007, Iași
Vectura Clinical Trial Site 21012, Judetul Iasi
Vectura Clinical Trial Site 21008, Iași
Vectura Clinical Trial Site 10029, North Dartmouth
Vectura Clinical Trial Site 31001, Lipa City
Vectura Clinical Trial Site 31002, Davao City
Vectura Clinical Trial Site 31003, Iloilo City
Vectura Clinical Trial Site 31004, Pasig
Vectura Clinical Trial Site 31005, Quezon City
Vectura Clinical Trial Site 31007, Quezon City
Vectura Clinical Trial Site 20018, Bialystok
Vectura Clinical Trial Site 20013, Biołystok
Vectura Clinical Trial Site 20015, Krakow
Vectura Clinical Trial Site 20019, Krakow
Vectura Clinical Trial Site 20009, Lodz
Vectura Clinical Trial Site 20012, Lublin
Vectura Clinical Trial Site 20008, Ostrów Wielkopolski
Vectura Clinical Trial Site 20003, Poznan
Vectura Clinical Trial Site 20005, Poznan
Vectura Clinical Trial Site 20016, Skiemiewice
Vectura Clinical Trial Site 20021, Tarnów
Vectura Clinical Trial Site 20010, Warsaw
Vectura Clinical Trial Site 20001, Wroclaw
Vectura Clinical Trial Site 20006, Wroclaw
Vectura Clinical Trial Site 20014, Zawadzkie
Vectura Clinical Trial Site 20007, Łodź
Vectura Clinical Trial Site 21011, Bucharest
Vectura Clinical Trial Site 23012, Kiev
Vectura Clinical Trial Site 23002, Kiev
Vectura Clinical Trial Site 23009, Kiev
Vectura Clinical Trial Site 23011, Kiev
Vectura Clinical Trial Site 23017, Kiev
Vectura Clinical Trial Site 23001, Kyiv
Vectura Clinical Trial Site 23003, Kyiv
Vectura Clinical Trial Site 23018, Kyiv
Vectura Limited
INDUSTRY